← Leaderboards
Jason V Baker
Hennepin Healthcare Research Institute
$8,161,548
Attributed
$14,489,594
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2014–25$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,489,594 · 7
By mechanism
R01$13,483,648 · 5
R34$669,055 · 1
R21$336,891 · 1
Top collaborators
- Lisa A Uebelacker5 shared
- Nigel S Key4 shared
- Mpiko Ntsekhe4 shared
- Chetan N Shenoy4 shared
- Russell P Tracy4 shared
- Keith Joseph Horvath3 shared
- Mpiko Ntsekhe2 shared
Most similar at Hennepin Healthcare Research Institute
Same institution · by research overlap
- Mpiko Ntsekhe$168,446
Others in their field
Top investigators on “Persons”
- Wafaa M. El-Sadr · Columbia University Health Sciences$688,439,560
- Lawrence Corey · Fred Hutchinson Cancer Center$646,462,796
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- David R. Weir · University Of Michigan At Ann Arbor$386,183,647
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$377,922,183
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$265,384,316
Research focus
PersonsAntiretroviral TherapyPhenotypeRisk FactorsCardiovascular Disorder RiskCardiovascular DiseasesViralClinical TrialsInflammationImmunologicsInflammatoryParticipantTissuesPathogenesisMonocyteFibrosisMediatingPathologyBiological MarkersOrganLifePathway InteractionsAgingHiv Seropositivity
Grant awards (28)
Optimization of a behavioral intervention to increase physical activity in older adults living with HIV$1,305,231
R01 · FY2025 · AG
Immunologic basis of cardiac disease after severe COVID-19$662,793
R01 · FY2025 · HL
Optimization of a behavioral intervention to increase physical activity in older adults living with HIV$677,007
R01 · FY2024 · AG
Immunologic basis of cardiac disease after severe COVID-19$671,068
R01 · FY2024 · HL
Clinical and immunologic factors underlying heart failure with preserved ejection fraction among persons with HIV in South Africa$513,760
R01 · FY2024 · HL · contact PI
Optimization of a behavioral intervention to increase physical activity in older adults living with HIV$357,663
R01 · FY2024 · AG
Optimization of a behavioral intervention to increase physical activity in older adults living with HIV$688,595
R01 · FY2023 · AG
Immunologic basis of cardiac disease after severe COVID-19$685,031
R01 · FY2023 · HL
Clinical and immunologic factors underlying heart failure with preserved ejection fraction among persons with HIV in South Africa$530,979
R01 · FY2023 · HL · contact PI
Optimization of a behavioral intervention to increase physical activity in older adults living with HIV$735,275
R01 · FY2022 · AG
Immunologic basis of cardiac disease after severe COVID-19$694,590
R01 · FY2022 · HL
Clinical and immunologic factors underlying heart failure with preserved ejection fraction among persons with HIV in South Africa$531,253
R01 · FY2022 · HL · contact PI
Clinical and immunologic factors underlying heart failure with preserved ejection fraction among persons with HIV in South Africa$537,987
R01 · FY2021 · HL · contact PI
PrEP iT! A Pilot Test of a Mobile Peer Support Intervention to Optimize PrEP Adherence and Retention in PrEP Care$206,731
R34 · FY2021 · MH
PrEP iT! A Pilot Test of a Mobile Peer Support Intervention to Optimize PrEP Adherence and Retention in PrEP Care$226,072
R34 · FY2020 · MH
Treatment to reduce inflammation and improve immune recovery among older HIV pts$385,743
R01 · FY2019 · AG · contact PI
PrEP iT! A Pilot Test of a Mobile Peer Support Intervention to Optimize PrEP Adherence and Retention in PrEP Care$236,252
R34 · FY2019 · MH
The Effects of Age and Treated HIV Infection on Myocardial Disease in South Africa$181,257
R21 · FY2019 · HL · contact PI
Treatment to reduce inflammation and improve immune recovery among older HIV pts$542,122
R01 · FY2018 · AG · contact PI
The Effects of Age and Treated HIV Infection on Myocardial Disease in South Africa$155,634
R21 · FY2018 · HL · contact PI
Targeted anticoagulant therapy to reduce inflammation in treated HIV disease$433,273
R01 · FY2017 · HL · contact PI
Targeted anticoagulant therapy to reduce inflammation in treated HIV disease$667,919
R01 · FY2016 · HL · contact PI
Treatment to reduce inflammation and improve immune recovery among older HIV pts$559,013
R01 · FY2016 · AG · contact PI
Targeted anticoagulant therapy to reduce inflammation in treated HIV disease$554,349
R01 · FY2015 · HL · contact PI
Treatment to reduce inflammation and improve immune recovery among older HIV pts$545,070
R01 · FY2015 · AG · contact PI
Targeted anticoagulant therapy to reduce inflammation in treated HIV disease$638,645
R01 · FY2014 · HL · contact PI
Treatment to reduce inflammation and improve immune recovery among older HIV pts$513,769
R01 · FY2014 · AG · contact PI
Treatment to reduce inflammation and improve immune recovery among older HIV pts$52,513
R01 · FY2014 · AG · contact PI